Company

Technology

Discover scalable, instrument-free single cell sequencing technology from Parse Bioscience

Technology Overview


Resources

Explore our collection of resources to learn more about technology and its applications from leading researchers

Resources Overview

Company

Providing researchers single cell sequencing with unprecedented scale and ease

About Parse

Technology

Discover scalable, instrument-free single cell sequencing technology from Parse Bioscience

Technology Overview

Uncovering Glioblastoma Heterogeneity in Solid Tumor and Tumor-derived in vitro Models


Glioblastoma remains the most common form of brain cancer, exhibiting enormous heterogeneity in the tumor and immune compartments, within both the same tumor and between patients. To characterize this heterogeneity within tumor samples and in vitro models, we utilized the Parse Evercode V2 assay to profile whole cells processed from a patient-derived neurosphere line, alongside nuclei isolated from a piece of flash-frozen glioblastoma tissue. Clustering of cells using Parse Analysis Pipeline revealed multiple distinct cell types from all samples, as demonstrated in the UMAP below.

Sample Table

DonorMaterialExposureProcessedName
1NeurosphereDMSOCellsVehicle Cell
1NeurosphereTMZCellsTreated Cell
2NeurosphereNucleiSphere Nuclei
2Frozen tissueNucleiTissue Nuclei

* The plate heatmap of the all-well summary, wells 7-10 are empty, having been removed due to patient privacy.

"We obtained an unprecedented number of genes per cell."

-Zac Moore, Walter and Eliza Hall Institute of Medical Research

We're your partners in single cell

Reach out for a quote or for help planning your next experiment.